Rapid generation of durable B cell memory to SARS-CoV-2 spike and nucleocapsid proteins in COVID-19 and convalescence

Hartley, Gemma E., Edwards, Emily S.J., Aui, Pei M., Varese, Nirupama, Stojanovic, Stephanie, McMahon, James, Peleg, Anton Y., Boo, Irene +4 more·2020·Science Immunology
DOI 10.1126/sciimmunol.abf8891

Cited by (295)

Items 101–200 of 295

  1. India’s pragmatic vaccination strategy against COVID-19: a mathematical modelling-based analysis
    Sandip Mandal, Nimalan Arinaminpathy, Balram Bhargava, Samiran Panda · 2021 · BMJ Open
  2. Robust and Functional Immune Memory Up to 9 Months After SARS-CoV-2 Infection: A Southeast Asian Longitudinal Cohort
    Hoa Thi My Vo, Alvino Maestri, Heidi Auerswald, Sopheak Sorn, Sokchea Lay, Heng Seng, Sotheary Sann, Nisa Ya, Polidy Pean, Philippe Dussart et al. · 2022 · Frontiers in Immunology
  3. Contributions of vibrational spectroscopy to virology: A review
    Iqra Ishtiaq Chaudhary, Naomi Jackson, Denise Denning, Luke A.J. O'Neill, Hugh James Byrne · 2022 · Clinical Spectroscopy
  4. Humoral immunity and B-cell memory in response to SARS-CoV-2 infection and vaccination
    Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Biochemical Society Transactions
  5. Dynamic changes of functional fitness, antibodies to SARS-CoV-2 and immunological indicators within 1 year after discharge in Chinese health care workers with severe COVID-19: a cohort study
    Lijuan Xiong, Qian Li, Xiongjing Cao, Huangguo Xiong, Ming Xing Huang, Fengwen Yang, Qingquan Liu, Daquan Meng, Mei Ling Zhou, Gang Wang et al. · 2021 · BMC Medicine
  6. Homologous but not heterologous COVID-19 vaccine booster elicits IgG4+ B-cells and enhanced Omicron subvariant binding
    Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Emily S.J. Edwards, Menno C. van Zelm · 2024 · npj Vaccines
  7. SARS‐CoV‐2 sculpts the immune system to induce sustained virus‐specific naïve‐like and memory B‐cell responses
    Leire de Campos‐Mata, Sonia Tejedor Vaquero, Roser Tachó‐Piñot, Janet Piñero, Emilie K. Grasset, Itziar Arrieta‐Aldea, Natalia Rodrigo Melero, Carlo Carolis, Juan Pablo Horcajada, Andrea Cerutti et al. · 2021 · Clinical & Translational Immunology
  8. Antibody Course and Memory B-Cell Response in the First Year After Severe Acute Respiratory Syndrome Coronavirus 2 Infection
    Judith Kannenberg, Henning Trawinski, Reinhard Henschler, Raymund Buhmann, Mario Hönemann, Christian Jassoy · 2022 · The Journal of Infectious Diseases
  9. COVID-19 Adenoviral Vector Vaccination Elicits a Robust Memory B Cell Response with the Capacity to Recognize Omicron BA.2 and BA.5 Variants
    Holly A. Fryer, Gemma E. Hartley, Emily S.J. Edwards, Nirupama P. Varese, Irene Boo, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Menno C. van Zelm · 2023 · Journal of Clinical Immunology
  10. Persistence of humoral response upon SARS‐CoV‐2 infection
    Andrea Knies, Dennis Ladage, Ralf J. Braun, Janine Kimpel, Miriam Schneider · 2021 · Reviews in Medical Virology
  11. The (apparent) antibody paradox in COVID-19
    Rohan Ameratunga, See‐Tarn Woon, Edward Lea, Richard Henderson Steele, Klaus Lehnert, Euphemia Yee Leung, Anna E. S. Brooks · 2022 · Expert Review of Clinical Immunology
  12. Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2
    Bruce D. Wines, Liriye Kurtovic, Halina M. Trist, Sandra E. Esparon, Ester López, Klasina Chappin, Li‐Jin Chan, Francesca L. Mordant, Wen Shi Lee, Nicholas A. Gherardin et al. · 2022 · Frontiers in Immunology
  13. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)–Specific Memory B Cells From Individuals With Diverse Disease Severities Recognize SARS-CoV-2 Variants of Concern
    Zoë L. Lyski, Amanda E. Brunton, Matt Strnad, Peter E. Sullivan, Sarah A. R. Siegel, Fikadu Tafesse, Mark K. Slifka, William B. Messer · 2021 · The Journal of Infectious Diseases
  14. Targeting the Complement–Sphingolipid System in COVID-19 and Gaucher Diseases: Evidence for a New Treatment Strategy
    Vyoma Snehal Trivedi, Albert Frank Magnusen, Reena Rani, Luca Marsili, Anne Michele Slavotinek, Daniel R. Prows, Robert James Hopkin, Mary Ashley McKay, Manoj K. Pandey · 2022 · International Journal of Molecular Sciences
  15. Detailed characterization of SARS-CoV-2-specific T and B cells after infection or heterologous vaccination
    Domenico Lo Tartaro, Annamaria Paolini, Marco Mattioli, Julian Swatler, Anita Neroni, Rebecca Borella, Elena Santacroce, Alessia Di Nella, Licia Gozzi, Stefano Busani et al. · 2023 · Frontiers in Immunology
  16. Recomendaciones SEPAR sobre la vacuna COVID-19 en las enfermedades respiratorias
    Felipe Villar Álvarez, Miguel Ángel Martínez‐García, David González Jiménez, Fernando Fariñas-Guerrero, Raúl Ortiz de Lejarazu-Leonardo, José Luís López-Campos, Marina Blanco‐Aparicio, Íñigo Royo-Crespo, Alberto García‐Ortega, Antoni Trilla García et al. · 2021 · Open Respiratory Archives
  17. Practical guidance for clinical laboratories for SARS-CoV-2 serology testing
    Carmen L. Charlton, Jamil N. Kanji, Vanessa Tran, Julianne V. Kus, Jonathan B. Gubbay, Carla Osiowy, Jason Lorne Robinson, Inna Sekirov, MICHAEL A. DREBOT, Todd F. Hatchette et al. · 2021 · Canada Communicable Disease Report
  18. Influence of environmental enrichment on circulating white blood cell counts and behavior of female turkeys
    Rebecca Lindenwald, Hans‐Joachim Schuberth, B. Spindler, Silke Rautenschlein · 2021 · Poultry Science
  19. New insights into human immune memory from SARS‐CoV ‐2 infection and vaccination
    Gemma E. Hartley, Emily S.J. Edwards, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Allergy
  20. Longitudinal clinico-serological analysis of anti-nucleocapsid and anti-receptor binding domain of spike protein antibodies against SARS-CoV-2
    Gururaj Rao Deshpande, Ojas Kaduskar, Ketki Deshpande, Vaishali Bhatt, Pragya Dhruv Yadav, Yogesh K. Gurav, Varsha Atul Potdar, Kirti Khutwad, Shankar Vidhate, Asha Salunke et al. · 2021 · International Journal of Infectious Diseases
  21. Mass Spectrometry Analysis of SARS-CoV-2 Nucleocapsid Protein Reveals Camouflaging Glycans and Unique Post-Translational Modifications
    Zeyu Sun, Xiaoqin Zheng, Feiyang Ji, Menghao Zhou, Xiaoling Su, Keyi Ren, Lanjuan Li · 2021 · Infectious Microbes & Diseases
  22. Assessment of Simulated Surveillance Testing and Quarantine in a SARS-CoV-2–Vaccinated Population of Students on a University Campus
    Francis C. Motta, Kevin A. McGoff, Anastasia Deckard, Cameron R. Wolfe, Mattia Bonsignori, Michael Anthony Moody, Kyle Cavanaugh, Thomas N. Denny, John Harer, Steven B. Haase · 2021 · JAMA Health Forum
  23. Mitochondrial regulation of acute extrafollicular B‐cell responses to COVID‐19 severity
    Tianyu Cao, Li Liu, Kelvin Kai‐Wang To, Chun‐Yu Lim, Runhong Zhou, Yue Ming, Ka‐Yi Kwan, Sulan Yu, Chun‐Yin Chan, Biao Zhou et al. · 2022 · Clinical and Translational Medicine
  24. COVID-2019 fundamentals
    Flavia Lamberghini, Fernando Daniel Testai · 2021 · The Journal of the American Dental Association
  25. Advances in understanding the formation and fate of B-cell memory in response to immunization or infection
    Liam C. Kealy, Kim L. Good‐Jacobson · 2021 · Oxford Open Immunology
  26. Fourth dose bivalent COVID-19 vaccines outperform monovalent boosters in eliciting cross-reactive memory B cells to Omicron subvariants
    Holly A. Fryer, Daryl Geers, Lennert Gommers, Luca M. Zaeck, Ngoc H. Tan, Bernadette Jones, Abraham Goorhuis, Douwe F. Postma, Leo G. Visser, Philip Mark Hogarth et al. · 2024 · Journal of Infection
  27. Prime-boost vaccination regimens with INO-4800 and INO-4802 augment and broaden immune responses against SARS-CoV-2 in nonhuman primates
    Jewell N. Walters, Blake Schouest, Ami R. Patel, Emma L. Reuschel, Katherine Schultheis, Elizabeth M. Parzych, Igor Maricic, Ebony Nicole Gary, Mansi Purwar, Viviane M. Andrade et al. · 2022 · Vaccine
  28. Vaccine subtype and dose interval determine immunogenicity of primary series COVID-19 vaccines in older people
    Helen Parry, Rachel K. Bruton, Reni Ayodele, Penny Sylla, Graham McIlroy, Nicola A. Logan, Sam Scott, Sam Nicol, Kriti Verma, Christine Stephens et al. · 2022 · Cell Reports Medicine
  29. T cell responses to SARS-CoV-2 in humans and animals
    Sameer-ul-Salam Mattoo, Jinjong Myoung · 2022 · The Journal of Microbiology
  30. Past SARS-CoV-2 infection elicits a strong immune response after a single vaccine dose
    Rossana Elena Chahla, Rodrigo Hernán Tomas‐Grau, Silvia I. Cazorla, Diego Ploper, Esteban Vera Pingitore, Mónica Aguilar López, Patricia Aznar, Malena Alcorta, Eva María del Mar Vélez, Agustín Stagnetto et al. · 2021 · medRxiv
  31. Health disparities in COVID-19: immune and vascular changes are linked to disease severity and persist in a high-risk population in Riverside County, California
    Kristina V. Bergersen, Kathy Pham, Jiang Li, Michael T. Ulrich, Patrick Merrill, Yuxin He, Sumaya Troy Alaama, Xinru Qiu, Indira S. Harahap-Carrillo, Keita Ichii et al. · 2023 · BMC Public Health
  32. Do Corticosteroid Injections for the Treatment of Pain Influence the Efficacy of mRNA COVID-19 Vaccines?
    Haewon Lee, Jennifer A. Punt, David C Miller, Ameet Nagpal, Clark Smith, Yusef A. Sayeed, Jaymin Patel, Milan P. Stojanovic, Adrian Popescu, Zachary L. McCormick · 2021 · Pain Medicine
  33. Evidence of Long-Lasting Humoral and Cellular Immunity against SARS-CoV-2 Even in Elderly COVID-19 Convalescents Showing a Mild to Moderate Disease Progression
    Bastian Fischer, Christopher Lindenkamp, Christoph Lichtenberg, Ingvild Birschmann, Cornelius Knabbe, Doris Hendig · 2021 · Life
  34. The second COVID ‐19 mRNA vaccine dose enhances the capacity of Spike‐specific memory B cells to bind Omicron BA .2
    Gemma E. Hartley, Emily S.J. Edwards, Nirupama P. Varese, Irene Boo, Pei Mun Aui, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Menno C. van Zelm · 2022 · Allergy
  35. Infection pre-Ad26.COV2.S-vaccination primes greater class switching and reduced CXCR5 expression by SARS-CoV-2-specific memory B cells
    Robert G. E. Krause, Thandeka Moyo-Gwete, Simone I. Richardson, Zanele Makhado, Nelia P. Manamela, Tandile Hermanus, Nonhlanhla N. Mkhize, Roanne S. Keeton, Ntombi Benede, Mathilda Mennen et al. · 2023 · npj Vaccines
  36. SARS-CoV-2 Infection Detection by PCR and Serologic Testing in Clinical Practice
    Douglas A. Murad, Sukantha Chandrasekaran, Ajaya Pillai, Omai B. Garner, Christopher T. Denny · 2021 · Journal of Clinical Microbiology
  37. SARS-CoV-2 Portrayed against HIV: Contrary Viral Strategies in Similar Disguise
    Ralf Duerr, Keaton M. Crosse, Ana M. Valero-Jimenez, Meike Dittmann · 2021 · Microorganisms
  38. Simultaneous enhancement of cellular and humoral immunity by the lymph node-targeted cholesterolized TLR7 agonist liposomes
    Dandan Wan, Ziyi Bai, Yu Zhang, Li Chen, Haiying Que, Tianxia Lan, Weiqi Hong, Jiayu Huang, He Cai, Yuquan Wei et al. · 2024 · Acta Pharmaceutica Sinica B
  39. Elucidating T Cell and B Cell Responses to SARS-CoV-2 in Humans: Gaining Insights into Protective Immunity and Immunopathology
    Aaruni Khanolkar · 2021 · Cells
  40. Durability and expansion of neutralizing antibody breadth following Ad26.COV2.S vaccination of mice
    Shant H. Mahrokhian, Lisa H. Tostanoski, Catherine Jacob-Dolan, Roland C. Zahn, Frank Wegmann, Katherine McMahan, Jingyou Yu, Makda S. Gebre, Esther Apraku Bondzie, Huahua Wan et al. · 2022 · npj Vaccines
  41. A FluoroSpot B assay for the detection of IgA and IgG SARS-CoV-2 spike-specific memory B cells: Optimization and qualification for use in COVID-19 vaccine trials
    Hélène Bisceglia, Julie Barrier, Joseline Ruiz, Anke Pagnon · 2023 · Journal of Immunological Methods
  42. Detection of SARS‐CoV‐2‐specific memory B cells to delineate long‐term COVID‐19 immunity
    Constantin J. Thieme, Mohamed Abou‐El‐Enein, Enrico Fritsche, Moritz Anft, Krystallenia Paniskaki, Sarah Skrzypczyk, Adrian Doevelaar, Magdi Elsallab, Nicola R. Brindle, Arturo Blazquez‐Navarro et al. · 2021 · Allergy
  43. Inferring linear-B cell epitopes using 2-step metaheuristic variant-feature selection using genetic algorithm
    Pratik Angaitkar, Turki Aljrees, Saroj Kumar Pandey, Ankit Kumar, Rekh Ram Janghel, Tirath Prasad Sahu, Kamred Udham Singh, Teekam Singh · 2023 · Scientific Reports
  44. An Overview of the Strategies to Boost SARS-CoV-2-Specific Immunity in People with Inborn Errors of Immunity
    Emma Chang-Rabley, Menno C. van Zelm, Emily Ricotta, Emily S.J. Edwards · 2024 · Vaccines
  45. COVID-19 progression and convalescence in common variable immunodeficiency patients show dysregulated adaptive immune responses and persistent type I interferon and inflammasome activation
    Javier Rodríguez‐Ubreva, Josep Calafell-Segura, Celia Lourdes Calvillo, Baerbel Keller, Laura Ciudad, Louis‐François Handfield, Carlos de la Calle‐Fabregat, Gerard Godoy‐Tena, Eduardo Andrés‐León, Regina Hoo et al. · 2024 · Nature Communications
  46. In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection
    Alessandra Romano, Nunziatina Laura Parrinello, Martina Barchitta, Rosy Manuele, Fabrizio Puglisi, Andrea Maugeri, Alessandro Barbato, Anna Maria Triolo, Cesarina Giallongo, Daniele Tibullo et al. · 2022 · Scientific Reports
  47. Humoral and cellular immunity against diverse SARS-CoV-2 variants
    Changxu Chen, Xin Wang, Zeli Zhang · 2023 · Journal of genetics and genomics/Journal of Genetics and Genomics
  48. Accurate determination of house dust mite sensitization in asthma and allergic rhinitis through cytometric detection of Der p 1 and Der p 2 binding on basophils (CytoBas)
    Lin Hsin, Nirupama P. Varese, Pei Mun Aui, Bruce D. Wines, Anouk von Borstel, Laurent Mascarell, Philip Mark Hogarth, Mark J Hew, Robyn E. O’Hehir, Menno C. van Zelm · 2024 · Journal of Allergy and Clinical Immunology
  49. The pivotal roles of the host immune response in the fine-tuning the infection and the development of the vaccines for SARS-CoV-2
    Wael Alturaiki, Ayman Mubarak, Abduallah Al Jurayyan, Maged Gomaa Hemida · 2021 · Human Vaccines & Immunotherapeutics
  50. Metabolic alterations unravel the maternofetal immune responses with disease severity in pregnant women infected with SARS‐CoV‐2
    Sandhya Hora, Prabhjyoti Pahwa, Hamda Siddiqui, Anoushka Saxena, Minal Kashyap, Jayesh Kumar Sevak, Ravinder Singh, Maryam Javed, Pushpa Yadav, Pratibha Ramchandra Kale et al. · 2023 · Journal of Medical Virology
  51. The immunological impact of revaccination in a hybrid-immune world
    Mary T. Bausch-Jurken, Galit Alter · 2025 · Frontiers in Immunology
  52. Simultaneous analysis of antigen‐specific B and T cells after SARS‐CoV‐2 infection and vaccination
    Krista L. Newell, Mitchell J. Waldran, Stephen James Thomas, Timothy P. Endy, Adam Tully Waickman · 2022 · Cytometry Part A
  53. Longevity of memory B cells and antibodies, as well as the polarization of effector memory helper T cells, are associated with disease severity in patients with COVID-19 in Bangladesh
    Marjahan Akhtar, Salima Raiyan Basher, Nuder Nower Nizam, Mohammad Kamruzzaman, Fatema Khaton, Hasan Al Banna, M. Hasanul Kaisar, Polash Chandra Karmakar, Al Hakim, Afroza Akter et al. · 2022 · Frontiers in Immunology
  54. Optimizing SARS-CoV-2 vaccination strategies in France: Results from a stochastic agent-based model
    Nicolas Hoertel, Martin Blachier, Frédéric Limosin, Marina Sánchez Rico, Carlos Blanco, Mark Olfson, Stéphane Luchini, Michaël Schwarzinger, Henri Leleu · 2021 · medRxiv
  55. High activation levels maintained in receptor‐binding domain–specific memory B cells in people with severe coronavirus disease 2019
    Money Gupta, Harikrishnan Balachandran, Raymond H. Y. Louie, Hui Li, David Agapiou, Elizabeth Keoshkerian, Daniel Christ, William D. Rawlinson, Michael Mina, Jeffrey John Post et al. · 2022 · Immunology and Cell Biology
  56. Plasmablasts in previously immunologically naïve COVID-19 patients express markers indicating mucosal homing and secrete antibodies cross-reacting with SARS-CoV-2 variants and other beta-coronaviruses
    Anna Lundgren, Susannah Leach, Hannes Axelsson, Pauline Isakson, Kristina Nyström, Lydia Scharf, Bengt A. Andersson, Nicolae Miron, Emelie Marklund, Lars‐Magnus Andersson et al. · 2023 · Clinical & Experimental Immunology
  57. Natural and hybrid immunity after SARS-CoV-2 infection in children and adolescents
    Tobias Rothoeft, C. Maier, A. Talarico, Armin Hoffmann, Anne Schlegtendal, Berit Lange, Astrid Petersmann, Robin Denz, Nina Timmesfeld, Nicole Toepfner et al. · 2024 · Infection
  58. EpiCurator: an immunoinformatic workflow to predict and prioritize SARS-CoV-2 epitopes
    Cristina dos Santos Ferreira, Yasmmin Martins, Rangel Celso Souza, Ana Tereza Ribeiro de Vasconcelos · 2021 · PeerJ
  59. Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.
    Ignacio Esteban, Georgina Bergero, Camila Alves, Micaela Bronstein, Valeria Ziegler, Cristian Wood, Mauricio T. Caballero, Diego Wappner, Romina Libster, Gonzalo Pérez Marc et al. · 2022 · Gates Open Research
  60. Comparative Analysis of Antibody Titers against the Spike Protein of SARS-CoV-2 Variants in Infected Patient Cohorts and Diverse Vaccination Regimes
    Alexandru Odainic, Jasper Spitzer, Jennifer Szlapa, Simon Schade, Tim Jonas Krämer, Jakob Neuberger, Christian Bode, Folkert Steinhagen, Ricarda Maria Schmithausen, Gero Wilbring et al. · 2022 · International Journal of Molecular Sciences
  61. Changing patterns of SARS-CoV-2 infection through Delta and Omicron waves by vaccination status, previous infection and neighbourhood deprivation: a cohort analysis of 2.7 M people
    Mark Alan Green, Daniel Hungerford, David Michael Hughes, Marta García‐Fiñana, Lance C. W. Turtle, Christopher Paul Cheyne, Matthew Ashton, Gary Leeming, Malcolm Gracie Semple, Alex David Singleton et al. · 2022 · BMC Infectious Diseases
  62. Analysis of Antigen‐Specific T and B Cells for Monitoring Immune Protection Against SARS‐CoV‐2
    Sara De Biasi, Annamaria Paolini, Domenico Lo Tartaro, Lara Gibellini, Andrea Cossarizza · 2023 · Current Protocols
  63. Detection of SARS-CoV-2 Nucleocapsid, Spike, and Neutralizing Antibodies in Vaccinated Japanese
    Rie Midorikawa, Moriyuki Nakama, Hiroshi Furukawa, Shomi Oka, Takashi Higuchi, Hideaki Nagai, Nobuhiro Nagai, Shigeto Tohma · 2022 · Viruses
  64. SARS-CoV-2-Specific Memory B Cell Responses Are Maintained After Recovery from Natural Infection and Postvaccination
    Tom Moore, Rojony Hossain, Katie J. Doores, Manu Shankar‐Hari, David J. Fear · 2022 · Viral Immunology
  65. Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipients
    Chethan Ashokkumar, Vinayak Rohan, Alexander Kroemer, Sohail Rao, George Vincent Mazariegos, Brandon W. Higgs, Satish N. Nadig, Jose Luis Almeda, Harmeet Dhani, Khalid Khan et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)
  66. Asymptomatic COVID-19 in the elderly: dementia and viral clearance as risk factors for disease progression.
    Ignacio Esteban, Georgina Bergero, Camila Alves, Micaela Bronstein, Valeria Ziegler, Cristian Wood, Mauricio T. Caballero, Diego Wappner, Romina Libster, Gonzalo Pérez Marc et al. · 2021 · Gates Open Research
  67. Immunologically relevant aspects of the new COVID-19 vaccines—an ÖGAI (Austrian Society for Allergology and Immunology) and AeDA (German Society for Applied Allergology) position paper
    Eva Untersmayr, Elisabeth Förster‐Waldl, Michael Markus Bonelli, Kaan Boztuǧ, Patrick Manfred Brunner, Thomas Eiwegger, Kathrin Eller, Lisa Göschl, Katharina Grabmeier‐Pfistershammer, Wolfram Hötzenecker et al. · 2021 · Allergo Journal International
  68. COVID ‐19 vaccine humoral response in frequent platelet donors with plateletpheresis‐associated lymphopenia
    Annemarie Laumaea, Antoine Lewin, Debashree Chatterjee, Lorie Marchitto, Shilei Ding, Gabrielle Gendron‐Lepage, Guillaume Goyette, Marie-Eve Allard, Carl Simard, Tony Tremblay et al. · 2022 · Transfusion
  69. Immunogenicity of BNT162b2 mRNA-Based Vaccine against SARS-CoV-2 in People with Cystic Fibrosis According to Disease Characteristics and Maintenance Therapies
    Gianfranco Alicandro, Valeria Daccò, Lisa Cariani, Chiara Rosazza, Calogero Sathya Sciarrabba, Federica Ferraro, Chiara Lanfranchi, Paola Medino, Daniela Girelli, Carla Colombo · 2022 · Biomedicines
  70. Korean Red Ginseng Relieves Inflammation and Modulates Immune Response Induced by Pseudo-Type SARS-CoV-2
    Ki Woong Kwon, Ji Won Kim, Seokoh Moon, Jeong Hyeon Yoon, Soo-Hyun Youn, Sun Hee Hyun, Han Gyung Kim, Dae‐Hyuk Kweon, Jae Youl Cho · 2023 · The American Journal of Chinese Medicine
  71. Immune Response 5–7 Months after Vaccination against SARS-CoV-2 in Elderly Nursing Home Residents in the Czech Republic: Comparison of Three Vaccines
    Jan Martínek, Hana Tomášková, Jaroslav Janošek, Hana Zelená, Alena Kloudová, Jakub Mrázek, Eduard Ježo, Vlastimil Král, Jitka Pohořská, Hana Šturcová et al. · 2022 · Viruses
  72. Herd immunity: challenges and the way forward in Korea
    Jiyoung Oh, Sohyun Kim, Boyeong Ryu, Minjoung Shin, Bryan Inho Kim · 2021 · Epidemiology and Health
  73. Third dose COVID-19 mRNA vaccine enhances IgG4 isotype switching and recognition of Omicron subvariants by memory B cells after mRNA but not adenovirus priming
    Gemma E. Hartley, Holly A. Fryer, Paul A. Gill, Irene Boo, Scott J. Bornheimer, Philip Mark Hogarth, Heidi E. Drummer, Robyn E. O’Hehir, Emily S.J. Edwards, Menno C. van Zelm · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  74. A Single Multiplex CytoBas Assay Incorporating Eight Major Components for Accurate Detection of Allergen Sensitization in Asthma and Allergic Rhinitis
    Lin Hsin, Mark J Hew, Pei Mun Aui, Kirsten Deckert, Philip Mark Hogarth, Robyn E. O’Hehir, Menno C. van Zelm · 2025 · Allergy
  75. Human memory T cell dynamics after aluminum-adjuvanted inactivated whole-virion SARS-CoV-2 vaccination
    Ece Tavukçuoğlu, Hamdullah Yanık, Mubaida Parveen, Sıla Ulutürk, Mine Durusu Tanrıöver, Ahmet Çağkan İnkaya, Murat Akova, Serhat Ünal, Güneş Esendağlı · 2023 · Scientific Reports
  76. Immune Responses in Discharged COVID-19 Patients With and Without Long COVID Symptoms
    Yeming Wang, Li Guo, Dan Cui, Hui Zhang, Qiao Zhang, Xiang Ren, Geng Wang, Xueyang Zhang, Tingxuan Huang, Lan Chen et al. · 2024 · Open Forum Infectious Diseases
  77. The comprehensive insights into the B-cells-mediated immune response against COVID-19 infection amid the ongoing evolution of SARS-CoV-2
    Manish K. Dhawan, Nanamika Thakur, Manish Kumar Sharma, Ali Ahmed Rabaan · 2025 · Biomedicine & Pharmacotherapy
  78. The protective immunity induced by SARS-CoV-2 infection and vaccination: a critical appraisal
    Eduardo Tosta · 2021 · Exploration of Immunology
  79. Steroid injections in pain management: influence on coronavirus disease 2019 vaccines
    Sung Man Hong, Yeon Wook Park, Eun Joo Choi · 2021 · The Korean journal of pain
  80. Detailed epitope mapping of SARS-CoV-2 nucleoprotein reveals specific immunoresponse in cats and dogs housed with COVID-19 patients
    Barbara Colitti, Francesco Bonfante, Santina Grazioli, Laura Anfossi, Chiara Nogarol, Daniela Scalas, Luigi Bertolotti, Alessio Bortolami, Matteo Pagliari, Giulia Pezzoni et al. · 2022 · Research in Veterinary Science
  81. Antibody Response to SARS-CoV-2 in Relation to the Contributing Factors in COVID-19 Patients
    Hafsa Aziz, Shazia Fatima, Humera Mahmood, Shahkhalid Muhammad, Muhammad Abdul Rehman Saeed, Shaista Khurshid, Wardah Aslam, Saeeda Aziz, Mohammad Faheem · 2022 · Viral Immunology
  82. Persistence and baseline determinants of seropositivity in health care workers up to nine months after COVID-19
    Carlota Dobaño, Anna Ramirez, Selena Alonso, Josep Vidal‐Alaball, Gemma Ruiz‐Olalla, Marta Vidal, Rocío Rubio, Emma Cascant, Daniel Parras, Natalia Rodrigo Melero et al. · 2021 · Research Square
  83. Long-term predictions of humoral immunity after two doses of BNT162b2 and mRNA-1273 vaccines based on dosage, age and sex
    Chapin S. Korosec, Suzan Farhang‐Sardroodi, David W. Dick, Samaneh Gholami, Mohammad Sajjad Ghaemi, Iain R. Moyles, Morgan Craig, Hsu Kiang Ooi, Jane Marie Heffernan · 2021 · medRxiv
  84. Population-based study of the durability of humoral immunity after SARS-CoV-2 infection
    David Peterhoff, Simon Wiegrebe, Sebastian Einhauser, Arisha Johanna Patt, Stephanie Beileke, Felix Günther, Philipp A. Steininger, Hans Helmut Niller, Ralph Burkhardt, Helmut Küchenhoff et al. · 2023 · Frontiers in Immunology
  85. Impact of corticosteroids on initiation and half-year durability of humoral response in COVID-19 survivors
    Yeming Wang, Li Guo, Guohui Fan, Han Yang, Qiao Zhang, Xiang Ren, Hui Zhang, Geng Wang, Xueyang Zhang, Tingxuan Huang et al. · 2024 · Chinese Medical Journal - Pulmonary and Critical Care Medicine
  86. Serological responses and clinical outcomes following a three‐dose primary COVID‐19 vaccine schedule in kidney transplant recipients and people on dialysis
    Dhakshayini Tharmaraj, Irene Boo, Jessie O’Hara, Shir Sun, Kevan Roy Polkinghorne, Claire Dendle, Stephen T. Turner, Menno C. van Zelm, Heidi E. Drummer, Gabriela Khoury et al. · 2024 · Clinical & Translational Immunology
  87. Identification of Human SARS-CoV-2 Monoclonal Antibodies from Convalescent Patients Using EBV Immortalization
    Rut Valgardsdottir, Irene Cattaneo, Gavino Napolitano, Annibale Raglio, Orietta Spinelli, Silvia Salmoiraghi, Concetta Castilletti, Daniele Lapa, Maria Rosaria Capobianchi, Claudio Farina et al. · 2021 · Antibodies
  88. COVID-19 in Cladribine-treated patient with multiple sclerosis
    Nitzan Haham, Adi Vaknin‐Dembinsky · 2021 · Journal of Neuroimmunology
  89. Cellular immunity in patients with COVID-19: molecular biology, pathophysiology, and clinical implications
    Sergey G. Sсherbak, Dmitry A. Vologzhanin, Александр Сергеевич Голота, Тatyana A. Kamilova, Станислав Вячеславович Макаренко · 2022 · Journal of clinical practice
  90. Impact of SARS-CoV-2-specific memory B cells on the immune response after mRNA-based Comirnaty vaccine in seronegative health care workers
    Alejandro Vallejo, Pilar Vizcarra, Adrián Martín-Hondarza, Sandra Gómez-Maldonado, Johannes Häemmerle, Héctor Velasco, José L. Casado · 2022 · Frontiers in Microbiology
  91. To be remembered: B cell memory response against SARS‐CoV ‐2 and its variants in vaccinated and unvaccinated individuals
    Nafees Ahmed, Atharv Athavale, Ankita Harishchandra Tripathi, Adarsh Subramaniam, Santosh Kumar Upadhyay, Anil Kumar Pandey, Ramesh Chandra Rai, Amit Awasthi · 2023 · Scandinavian Journal of Immunology
  92. Unravelling humoral immunity in SARS-CoV-2: Insights from infection and vaccination
    Nouhaila Najimi, Chaimae Kadi, Noureddine Elmtili, Fouad Seghrouchni, Youssef Bakri · 2024 · Human Antibodies
  93. Should SARS-CoV-2 serological testing be used in the decision to deliver a COVID-19 vaccine booster? A pro-con assessment
    Matteo Augello, Isabell Wagenhäuser, Manuel Krone, Nicolás Dauby, Pietro Ferrara, Michela Sabbatucci, Simona Maria Ruță, Omid Rezahosseini, Petar Velikov, Effrossyni Gkrania‐Klotsas et al. · 2024 · Vaccine
  94. SARS-CoV-2 immunogenicity in individuals infected before and after COVID-19 vaccination: Israel, January–March 2021
    Kamal Abu Jabal, Hila Ben-Amram, Karine Beiruti Wiegler, Ira Brimat, Ashraf Abu Saada, Younes Bathish, Christian Sussan, Salman Zarka, Michael L. Edelstein · 2021 · Epidemiology and Infection
  95. A surrogate cell‐based SARS‐CoV‐2 spike blocking assay
    Wolfgang Schuh, Lena Baus, Tobit D. Steinmetz, Sebastian R. Schulz, Leonie Weckwerth, Edith A. Roth, Manuela Hauke, Sara K. Krause, Patrick Morhart, Manfred Rauh et al. · 2021 · European Journal of Immunology
  96. Formation and Expansion of Memory B Cells against Coronavirus in Acutely Infected COVID-19 Individuals
    A. Embong, Phuong Nguyen-Contant, Jiong Wang, Preshetha Kanagaiah, F. Chaves, T. Fitzgerald, Qian Zhou, G. Kosoy, A. Branche, Benjamin L. Miller et al. · 2022 · Pathogens
  97. Severe Acute Respiratory Syndrome Coronavirus 2 Cross-Reactive B and T Cell Responses in Kidney Transplant Patients
    Krystallenia Paniskaki, Moritz Anft, Constantin J. Thieme, Sarah Skrzypczyk, Margarethe Konik, Sebastian Dolff, Timm Henning Westhoff, Mikalai Nienen, Anna Stittrich, Ulrik Stervbo et al. · 2022 · Transplantation Proceedings
  98. Theoretical Explanation for the Rarity of Antibody-Dependent Enhancement of Infection (ADE) in COVID-19
    Anna E. Boldova, Julia-Jessica D. Korobkin, Yury D. Nechipurenko, Anastasia N. Sveshnikova · 2022 · International Journal of Molecular Sciences
  99. Associating SARS-CoV-2 Serological Assays with Protection: Where the Field Stands
    Mei San Tang, Christopher W Farnsworth · 2021 · Clinical Chemistry
  100. SARS-CoV-2-specific memory B cells can persist in the elderly despite loss of neutralising antibodies
    Anna Jeffery-Smith, Alice R. Burton, Sabela Lens, Chloe Rees-Spear, Monika Patel, Robin Gopal, Luke Muir, Felicity Aiano, Katie J. Doores, J. Yimmy Chow et al. · 2021 · bioRxiv (Cold Spring Harbor Laboratory)